San Carlos, CA, United States of America

Shyr Jiann Li

This inventor holds 1 USPTO granted patent. Top assignee: Attovia Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shyr Jiann Li. Retrieved from https://idiyas.com/inventor/shyr-jiann-li-e2ai11vx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shyr Jiann Li: Innovator in Polypeptide Technology

Introduction

Shyr Jiann Li is a notable inventor based in San Carlos, California. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides. His innovative work has led to the filing of a patent that showcases his expertise and creativity.

Latest Patents

Shyr Jiann Li holds a patent for "IL31-BINDING POLYPEPTIDES AND USES THEREOF." This patent highlights his research and development efforts in creating polypeptides that have potential applications in various therapeutic areas. The patent reflects his commitment to advancing scientific knowledge and improving healthcare solutions.

Career Highlights

Li is currently employed at Attovia Therapeutics, Inc., where he continues to work on groundbreaking projects. His role at the company allows him to collaborate with other talented professionals in the field. His career is marked by a dedication to innovation and a passion for scientific discovery.

Collaborations

Some of his notable coworkers include Jin Wook Choi and David Bellovin. Together, they contribute to the dynamic research environment at Attovia Therapeutics, Inc. Their collaborative efforts enhance the potential for developing new therapeutic solutions.

Conclusion

Shyr Jiann Li is a distinguished inventor whose work in polypeptide technology is paving the way for future advancements in biotechnology. His patent and contributions to Attovia Therapeutics, Inc. exemplify his commitment to innovation and scientific progress.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…